BLU-5937: First-in-Human, Single and Multiple Doses Escalation, Safety, Tolerability, Pharmacokinetics and Food Effect
Clinical trial NCT03638180 · COMPLETED
Trial details
- NCT number
- NCT03638180
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2018-10-25
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.